SunTrust Starts Alexion Pharmaceuticals (ALXN) at Buy
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 10
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 10
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Alexion Pharmaceuticals (NASDAQ: ALXN) with a Buy rating and a price target of $229.00.
For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $169.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Resumes Dada Nexus Ltd. (DADA) at Neutral
- Goldman Sachs Starts Victoria's Secret (VSCO) at Sell, 'Tough macro and ongoing competitive pressures'
- Cantor Fitzgerald Starts Materialise NV (MTLS) at Overweight, 'Well-Positioned to meet rising software demand'
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
